{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:03:56Z","timestamp":1774343036221,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012286","name":"Kermanshah University of Medical Sciences Vice Chancellor for Research and Technology","doi-asserted-by":"publisher","award":["4000604"],"award-info":[{"award-number":["4000604"]}],"id":[{"id":"10.13039\/501100012286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126424","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T09:43:53Z","timestamp":1729071833000},"page":"126424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gender differences in adverse effects following the second dose of AstraZeneca COVID-19 vaccine: a cross-sectional study among healthcare workers"],"prefix":"10.1016","volume":"42","author":[{"given":"Masoud","family":"Sedaghat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badriyeh","family":"Karami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Khosravi","family":"Shadmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahab","family":"Rezaeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2024.126424_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/HAB-200420","article-title":"Global burden of COVID-19: Situational analyis and review","volume":"29","author":"Gebru","year":"2021","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.vaccine.2024.126424_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/CEOR.S338225","article-title":"Economic Burden of COVID-19: A Systematic Review","volume":"14","author":"Richards","year":"2022","journal-title":"Clinicoecon Outcomes Res"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126424_bb0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jech-2021-216690","article-title":"COVID-19 pandemic and its impact on social relationships and health","volume":"76","author":"Long","year":"2022","journal-title":"J Epidemiol Community Health"},{"issue":"7820","key":"10.1016\/j.vaccine.2024.126424_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","article-title":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe","volume":"584","author":"Flaxman","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126424_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2020.178","article-title":"COVID-19 vaccine: critical questions with complicated answers","volume":"29","author":"Haidere","year":"2021","journal-title":"Biomol Ther"},{"issue":"1645","key":"10.1016\/j.vaccine.2024.126424_bb0030","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126424_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14760584.2020.1825951","article-title":"Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations","volume":"19","author":"Sultana","year":"2020","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126424_bb0040","first-page":"1646","article-title":"Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases","volume":"18","author":"Yaamika","year":"2023","journal-title":"J Taibah Univ Med Sci"},{"key":"10.1016\/j.vaccine.2024.126424_bb0045","series-title":"The Oxford\/AstraZeneca COVID-19 vaccine: what you need to know","author":"Organization, W.H","year":"2021"},{"key":"10.1016\/j.vaccine.2024.126424_bb0050","series-title":"Guidance | Worried about having your second dose of AstraZeneca vaccination?","author":"PH., E","year":"2021"},{"issue":"10269","key":"10.1016\/j.vaccine.2024.126424_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.126424_bb0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11739-021-02685-0","article-title":"Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine","volume":"16","author":"Carli","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126424_bb0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3947\/ic.2021.0044","article-title":"Survey of adverse events after the first dose of the ChAdOx1 nCoV-19 vaccine: a single-center experience in Korea","volume":"53","author":"Song","year":"2021","journal-title":"Infection & Chemotherapy"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126424_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/vaccines9060673","article-title":"Safety of ChAdOx1 nCoV-19 vaccine: independent evidence from two EU states","volume":"9","author":"Riad","year":"2021","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126424_bb0075","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.34172\/ipp.2021.31","article-title":"Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion","volume":"7","author":"Ghiasi","year":"2021","journal-title":"Immunopathologia Persa"},{"key":"10.1016\/j.vaccine.2024.126424_bb0080","first-page":"70","article-title":"First month of COVID-19 vaccine safety monitoring\u2014United States, December 14, 2020\u2013January 13","volume":"2021","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126424_bb0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/vaccines9080911","article-title":"Age-and sex-graded data evaluation of vaccination reactions after initial injection of the BNT162b2 mRNA vaccine in a local vaccination center in Germany","volume":"9","author":"Hoffmann","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126424_bb0090","article-title":"COVID-19 vaccine side effect: Age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia: A community-based study","volume":"10","author":"Alemayehu","year":"2022","journal-title":"SAGE Open Medicine"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126424_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000265","article-title":"Gender disparities and associated factors to intention to getting a second dose of COVID-19 AstraZeneca vaccine among adult populations in selected facilities of Lusaka, Zambia","volume":"2","author":"Jacobs","year":"2022","journal-title":"PLOS global public health"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126424_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/vaccines10020223","article-title":"Prospective evaluation of side-effects following the first dose of Oxford\/AstraZeneca COVID-19 vaccine among healthcare workers in Saudi Arabia","volume":"10","author":"Darraj","year":"2022","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126424_bb0105","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/biology10080752","article-title":"Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers","volume":"10","author":"Klugar","year":"2021","journal-title":"Biology"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126424_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274526","article-title":"Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy","volume":"17","author":"Darweesh","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126424_bb0115","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.18549\/PharmPract.2022.2.2678","article-title":"COVID-19 vaccination, do women suffer from more side effects than men? A retrospective cross-sectional study","volume":"20","author":"Al-Qazaz","year":"2022","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.vaccine.2024.126424_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106700","article-title":"COVID-19 vaccines: Considering sex differences in efficacy and safety","volume":"115","author":"Jensen","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.vaccine.2024.126424_bb0130","article-title":"COVID-19 vaccine side effect: age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia: a community-based study","volume":"10","author":"Alemayehu","year":"2022","journal-title":"SAGE Open Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126424_bb0135","article-title":"Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine","volume":"10","author":"Green","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126424_bb0140","article-title":"Factors Associated with Adverse Reactions to BNT162b2 COVID-19 Vaccine in a Cohort of 3969 Hospital Workers","volume":"10","author":"Rivera-Izquierdo","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"27","key":"10.1016\/j.vaccine.2024.126424_bb0145","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126424_bb0150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126424_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/vaccines10020233","article-title":"Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine","volume":"10","author":"Green","year":"2022","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126424_bb0160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2401106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2401106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:43:23Z","timestamp":1741887803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2401106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X2401106X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126424","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender differences in adverse effects following the second dose of AstraZeneca COVID-19 vaccine: a cross-sectional study among healthcare workers","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126424"}}